COM:NEXIMMUNE
NexImmune
- Stock
Last Close
0.22
22/11 15:32
Market Cap
3.17M
Beta: -
Volume Today
1.67K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
net income | -12.83M - | -20.55M 60.10% | -29.87M 45.36% | -50.90M 70.43% | -62.51M 22.80% | -32.34B 51,645.90% | |
depreciation and amortization | 204.65K - | 436.37K 113.23% | 618.99K 41.85% | 870.28K 40.60% | 994.79K 14.31% | 1.02B 102,933.90% | |
deferred income tax | 442.13K - | -3.29M 844.60% | |||||
stock based compensation | 1.21M - | 1.53M 27.19% | 1.22M 20.67% | 5.98M 391.28% | 5.87M 1.83% | 3.55B 60,435.02% | |
change in working capital | 304.05K - | -842.11K 376.96% | -89.43K 89.38% | 654.57K 831.93% | 3.93M 500.31% | -1.04B 26,593.82% | |
accounts receivables | |||||||
inventory | |||||||
accounts payables | 191.95K - | 235.11K 22.48% | 702.47K 198.78% | -1.00M 242.77% | 1.39M 238.31% | -1.04B 75,155.17% | |
other working capital | 112.10K - | -1.08M 1,060.98% | -791.90K 26.49% | 1.66M 309.30% | 2.54M 53.39% | 1.04B 40,848.17% | |
other non cash items | 2.48K - | 1.27M 51,206.90% | 903.92K 28.96% | 520.69K 42.40% | -3.66B 703,902.68% | ||
net cash provided by operating activities | -11.12M - | -19.42M 74.62% | -26.40M 36.00% | -45.79M 73.40% | -51.19M 11.81% | -31.43B 61,298.38% | |
investments in property plant and equipment | -937.77K - | -1.25M 32.85% | -864.66K 30.60% | -2.35M 171.83% | -1.26M 46.60% | -48.72M 3,781.71% | |
acquisitions net | -32.06M - | 80.80K 100.25% | |||||
purchases of investments | -17.61M - | -7.07M 59.84% | -90.46M - | -21.51M 76.22% | |||
sales maturities of investments | 5.95M - | 17.73M 198.06% | 1.01M 94.32% | 39M 3,775.31% | 73M 87.18% | ||
other investing activites | -40.13K - | 9.90K 124.68% | 80.22K 709.93% | 32.06M 39,869.34% | 4.23M - | ||
net cash used for investing activites | -12.64M - | 9.42M 174.53% | 221.94K 97.64% | -53.81M 24,344.50% | 50.32M 193.51% | -44.49M 188.43% | |
debt repayment | -7.28K - | -18.44K 153.29% | -19.89K 7.87% | -12.26K 38.35% | |||
common stock issued | 18.78M - | 6.60K 99.96% | 114.72M 1,737,052.00% | 5.15M 95.51% | |||
common stock repurchased | |||||||
dividends paid | |||||||
other financing activites | 9.19M - | 22.10M - | 10.18M 53.94% | 33.26K 99.67% | |||
net cash used provided by financing activities | 9.18M - | 18.76M 104.40% | 22.08M 17.69% | 124.89M 465.49% | 5.18M 95.85% | ||
effect of forex changes on cash | |||||||
net change in cash | -14.58M - | 8.77M 160.16% | -4.10M 146.72% | 25.30M 717.27% | 4.30M 82.99% | -31.47B 731,480.87% | |
cash at beginning of period | 15.01M - | 426.00K 97.16% | 9.20M 2,058.83% | 5.10M 44.56% | 30.39M 496.12% | 34.70B 114,059.07% | |
cash at end of period | 426.00K - | 9.20M 2,058.83% | 5.10M 44.56% | 30.39M 496.12% | 34.70M 14.16% | 3.22B 9,187.32% | |
operating cash flow | -11.12M - | -19.42M 74.62% | -26.40M 36.00% | -45.79M 73.40% | -51.19M 11.81% | -31.43B 61,298.38% | |
capital expenditure | -937.77K - | -1.25M 32.85% | -864.66K 30.60% | -2.35M 171.83% | -1.26M 46.60% | -48.72M 3,781.71% | |
free cash flow | -12.06M - | -20.66M 71.38% | -27.27M 31.98% | -48.14M 76.52% | -52.45M 8.96% | -31.48B 59,921.92% |
All numbers in (except ratios and percentages)